Category: FDA

Have you noticed that TV drug commercials almost never talk about prices? This, along with ongoing anger about rising drug costs, prompted the Trump administration to enact a rule that will require drug manufacturers to disclose list prices of medications in commercials starting this summer—a rule that drug makers are now fighting. The regulation of… Read More

The FDA has just approved Nayzilam, the first new medication to treat seizure clusters in more than 20 years. The new drug is approved for the short-term treatment of seizure clusters in patients with epilepsy, and is the only FDA-approved nasal spray option for treating seizures of any kind. Epilepsy, a disease characterized by recurrent… Read More

Last month, the FDA approved Eticovo, the second biosimilar for top-selling rheumatoid arthritis drug, Enbrel. Enbrel’s first biosimilar, Erelzi, was approved in 2016. Eticovo will soon be available at a reduced cost compared to Enbrel and is just one of many biosimilars that manufacturer Samsung Bioepis has been working on in their effort to increase… Read More

Starting in two months, drug manufacturers will be required to display list prices in TV ads for treatments costing more than $35 a month, a step that Alex Azar, Secretary of Health and Human Services (HHS), called “monumental” in terms of putting patients in control of their healthcare costs. Let’s look at what these list… Read More

In an effort to curb the current opioid epidemic and make treatment more accessible, the FDA approved the first generic naloxone nasal spray used to reverse opioid overdoses. This generic, which will soon be available on the market, is the counterpart to brand-name Narcan. Like the brand drug, it will be easy to use and… Read More

Back in March, the FDA approved a generic to the popular pulmonary arterial hypertension medication Letairis, and now it is available in pharmacies as ambrisentan. Unfortunately, though, ambrisentan isn’t cheap, and you may need to jump through some hoops to get your prescription. What is ambrisentan for? is used to treat pulmonary arterial hypertension (PAH),… Read More

Mavenclad, a new medication for multiple sclerosis was just approved, but unfortunately, it won’t be cheap—cash-paying patients may need to shell out as much as $100,000 per year or $200,000 for a full treatment course. Here’s what you need to know. What is Mavenclad for? is approved to treat multiple sclerosis (MS), a chronic condition… Read More

The FDA has just approved the first oral testosterone medication ever, Jatenzo, to treat men with hypogonadism, or low testosterone levels, due to certain medical conditions. Jatenzo is an exciting addition to existing treatment options for these patients whose previous choices only consisted of testosterone injections or cream. However, Jatenzo should not be used by… Read More

Lawmakers in D.C. may be working on bills to curb skyrocketing drug prices, but prices continue to move up. This March, manufacturer Gilead increased list prices for all of their drugs—including Truvada for PrEP—by practically 5%. Unfortunately, the price hikes don’t stop there. List prices for the popular drugs, Belviq, Belviq XR, and Banzel (made… Read More

Life after having a baby can be stressful. After giving birth, you have to navigate new motherhood, exhaustion, and bodily changes. Many new mothers also encounter postpartum depression (PPD)—and adding that to the mix can be overwhelming. Postpartum depression is defined as depression suffered by a mother following childbirth, typically arising from the combination of… Read More